IDCRC Newsletter: March 2026

2026 Annual Meeting Speakers and Schedule

We look forward to meeting for the 2026 IDCRC Annual Meeting on Wednesday, May 13, and Thursday, May 14, in Rockville, MD. We're excited to share this year's keynote speakers and the schedule of events below. Stay tuned for further event details!

IDCRC Admin Spotlight: Sidnee Young

This month's IDCRC spotlight features Sidnee Young, administrative director for the IDCRC. Learn more about our colleague below!

"Having the opportunity to work in the administrative operations of vaccine and therapeutic testing and development while in the midst of a global pandemic was one of the most frightening and invaluable experiences of my life. Being a very small part of that tremendous work has permanently shaped me professionally and personally."

Publications

NOTE: Please include the following citation in any publications resulting from direct or indirect IDCRC support: 

"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

View recent publications and updated quick stats below:

• Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study
• Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines
• Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

News

UWMedicine News | "Newly elected members of the American Society of Clinical Investigation," with Helen Chu, MD

NIH News in Health | "Navigating Norovirus, Insights Into Stomach Bug Outbreaks," with Robert Atmar, MD

NIH-funded researchers are now studying the virus using tiny 3D models of human intestines. These are called “mini-guts.” Scientists can expose these intestinal cells to noroviruses in the lab. After infecting a mini-gut, the virus begins to make copies of itself. “This process allows us to study the cells’ responses to infection and test potential antivirals that can block the infection,” says Dr. Robert Atmar, an infectious disease expert at Baylor College of Medicine.

The Washington Post | "As measles cases climb, these 9 diseases threaten comebacks," with Karen Kotloff, MD

Measles is the most contagious disease known and can be serious, especially for young children. It spreads when a person coughs or sneezes and can cause a distinctive rash with flat red spots, along with fever and upper respiratory symptoms. More severe complications sometimes develop, such as pneumonia and encephalitis. Before a vaccine was available, measles was responsible for an estimated 2.6 million deaths a year.

Vanderbilt Health News | "Vanderbilt research offers new hope for preventing repeated C. diff infections," with Buddy Creech, MD

Lacy Borden, PhD, Edward and Nancy Fody Chair in Pathology, and her colleagues are working on potential vaccines, therapeutic antibodies, and — most recently — nanobodies, to prevent and treat infections by the bacterium known by its scientific name as Clostridioides difficile. Since 2011, her research has been funded continuously by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, and her team has published more than 40 scientific papers on C. diff and its toxins.

Job Postings

Newly Posted! Infectious Diseases Research Job Openings

• Cincinnati Children’s Hospital - Infectious Diseases - Associate Medical Director of Infection Prevention & Control, -Assistant/Associate Professor 
• Hartford Hospital - Antimicrobial Research and Infectious Diseases Fellowship at the Center for Anti-Infective Research and Development

• NYU Langone Health - Microbial Immunity and Pathogenesis Faculty Positions 

• State of Hawaii, Department of Health - Epidemiological Specialist I, II, III, IV  

• Virginia Commonwealth University - Open Rank Faculty - Infectious Disease Epidemiology

Visit the IDSA Career Center to browse other ID job postings.

Events

Upcoming NIH Webinar

NIH seeks community feedback on the next agency-wide strategic plan. This plan will guide our work over the next five years to fulfill our mission for the American people. Input from the research community, stakeholders, and the public is essential to ensure transparency in what we do and advance the principles of gold standard science that we all apply to our daily work.

In this webinar, the NIH leadership will:

• Introduce the process for developing the next NIH-Wide Strategic Plan
• Outline the high-level framework
• Answer attendees’ questions

Infectious Disease Board Review Course

The 2026 Infectious Disease Board Review Live Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification and recertification exams. This comprehensive course includes web access to the entire archived course plus primers and study guides, online-only lectures, photo-based questions, and over 500 ABIM-style questions.

Can't attend in person? The livestream allows you to participate in the course from any location as long as you have an internet connection. The webcast will take place in the Eastern time zone, and all agenda items reflect that. All sessions will be recorded and made available to all registrants within 24 hours should you miss the live webcast.

Participants can earn up to 117 CME credits and MOC points. This course is accredited by The George Washington University School of Medicine and Health Sciences.

Funding Opportunities

IDCRC Studies

Fully Enrolled Studies in Follow-up

• A Randomized, Double-Blind, Placebo-Controlled Phase 1 Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of Sanaria(R) PfSPZ-LARC2 Vaccine, a Late-Arresting, Replication-Competent, Genetically Attenuated Plasmodium Falciparum Vaccine by Controlled Human Malaria Infection in Malaria-Naïve Healthy Adults Conditions (DMID 23-0010)
• Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults (DMID 23-0006)

• A Phase 1 Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001B WNV in Healthy Adults (DMID 24-0008)

• A Prospective, Randomized, Open-label Phase 4 Study of the Immunology and Safety of Maternal RSV Vaccination (ABRYSVOTM), Infant Nirsevimab (BEYFORTUSTM) Immunization, or Both Products During the First Year of Life (PROMISE) (DMID 24-0003)

IDCRC Concept Quick Stats

Communication Resources

Please submit IDCRC news to idcrc@emory.edu for inclusion in the monthly newsletter and IDCRC.org.